← All trials
NCT05565807
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 23, 2022
- Primary completion
- Mar 7, 2025
- Completion date
- Feb 19, 2027
- First posted
- Oct 4, 2022
- Last posted
- Oct 4, 2022
- Enrollment
- 84
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Acea BioLead sponsor
- Zhejiang UniversityOverall official - principal investigator
- Sun Yat-Sen UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.